Potassium Carbonate → 7-(3,4-diethylphenyl)-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1H-1-benzazepine-4-carboxamide
Reaction equation
B([O-])([O-])O[C:3]1[CH:8]=[CH:7][C:6]([CH2:9][CH3:10])=[C:5]([CH2:11][CH3:12])[CH:4]=1.Br[C:16]1[CH:17]=[CH:18][C:19]2[N:25]([CH3:26])[CH2:24][CH2:23][C:22]([C:27]([NH:29][C:30]3[CH:35]=[CH:34][C:33]([CH2:36][N:37]([CH3:44])[CH:38]4[CH2:43][CH2:42][O:41][CH2:40][CH2:39]4)=[CH:32][CH:31]=3)=[O:28])=[CH:21][C:20]=2[CH:45]=1.C(=O)([O-])[O-].[K+].[K+]>O.C(O)C.C1(C)C=CC=CC=1.C(OCC)(=O)C.C1C=CC([P]([Pd]([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)([P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)[P](C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)(C2C=CC=CC=2)C2C=CC=CC=2)=CC=1>[CH2:11]([C:5]1[CH:4]=[C:3]([C:16]2[CH:17]=[CH:18][C:19]3[N:25]([CH3:26])[CH2:24][CH2:23][C:22]([C:27]([NH:29][C:30]4[CH:31]=[CH:32][C:33]([CH2:36][N:37]([CH3:44])[CH:38]5[CH2:43][CH2:42][O:41][CH2:40][CH2:39]5)=[CH:34][CH:35]=4)=[O:28])=[CH:21][C:20]=3[CH:45]=2)[CH:8]=[CH:7][C:6]=1[CH2:9][CH3:10])[CH3:12]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 3
Procedure
In a mixture of water:ethanol:toluene (1:1:10, v/v, 18.0 ml) were dissolved 3,4-diethylphenyl borate (264 mg) and 7-bromo-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1H-1-benzazepine-4-carboxamide (406 mg), and to the solution was added potassium carbonate (162 mg). The mixture was stirred under argon atmosphere at room temperature for 30 minutes, and to the mixture was added tetrakistriphenylphosphinepalladium (39 mg). The mixture was refluxed under argon atmosphere for 13 hours, diluted with ethyl acetate and washed with water and saturated brine, and the organic layer was dried with anhydrous magnesium sulfate. The solvent was evaporated under reduced pressure, and the residue was purified with silica gel column chromatography (45 g, ethyl acetate:ethanol=20:1) and recrystallized from ethanol to give 7-(3,4-diethylphenyl)-1-methyl-N-[4-[[N-methyl-N-(tetrahydro-2H-pyran-4-yl)amino]methyl]phenyl]-2,3-dihydro-1H-1-benzazepine-4-carboxamide (263 mg, 55%) as yellow crystals.
Workup
- temperatureThe mixture was refluxed under argon atmosphere for 13 hours
- washwashed with water and saturated brine
- dry with materialthe organic layer was dried with anhydrous magnesium sulfate
- customThe solvent was evaporated under reduced pressure
- customthe residue was purified with silica gel column chromatography (45 g, ethyl acetate:ethanol=20:1)
- customrecrystallized from ethanol
Sources & evidence
- ORD record
- ord-7d9f6a93d26f4a6fbb5c93545193147a
- Source dataset
- uspto-grants-2005_08
- Patent number
- US06936602B1
Reaction notes
Loading…